Cargando…
Vaccine innovation model: A technology transfer perspective in pandemic contexts
This work identifies the innovations that made it possible for the Bio-Manguinhos/Fiocruz Immunobiological Technology Institute to engage in the entire production of the Oxford/AstraZeneca vaccine (ChAdOx1 nCov-19) in Brazil, just 1.8 years after the COVID-19 pandemic was declared. The results were...
Autores principales: | Medeiros, Maurício Z., Soares, Priscila F., Fialho, Beatriz C., Gauss, Leandro, Piran, Fábio S., Lacerda, Daniel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236274/ https://www.ncbi.nlm.nih.gov/pubmed/35773123 http://dx.doi.org/10.1016/j.vaccine.2022.06.054 |
Ejemplares similares
-
Vaccine Innovation Meta-Model for Pandemic Contexts
por: Fialho, Beatriz C., et al.
Publicado: (2023) -
Technology transfer, innovation and international competitiveness
por: Gee, Sherman
Publicado: (1981) -
The role of standardization in CERN's innovation and technology transfer process
por: CHESTA, Enrico
Publicado: (2014) -
Workshop on the Role of Technology-transfer Projects in the Innovation Process
por: Guy, Ken
Publicado: (1996) -
Spatiotemporal characteristics and influencing factor analysis of universities’ technology transfer level in China: The perspective of innovation ecosystems
por: Fang, Haining, et al.
Publicado: (2022)